Funda Meric-Bernstam

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis o...

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the gerandomis...

21-genen assay en chemotherapievoordeel bij klierpositief mammacarcinoom: RxPONDER fase III

Vorinostat plus sirolimus of everolimus bij recidief/refractair HL

DFS en OS bij HER2-positief mammacarcinoom onder anti-HER2 behandeling: HERA/NSABP B-31 analyse